1887

Abstract

SUMMARY

Two mouse cytotoxic T cell (Tc) clones, D5 and H1 la, with specificity for the respiratory syncytial virus (RSV) fusion protein (F) were derived from BALB/c mice primed intranasally (i.n.) with RSV (A2 strain). These clones possessed essentially the same characteristics, and only clone H1 1a is described here. Tc clone H1 1a lysed target cells infected with a recombinant vaccinia virus (VV) expressing the RSV F gene, and similar target cells infected with RSV strains Long, 8/60, or 18537. In addition, two RSV-specific mouse Tc lines are described, from BALB/c mice primed i.n. with RSV A2 (Tc line MJC-A2), or intraperitoneally with a VV–RSV F gene recombinant (Tc line MJC-F). Tc line MJC-A2 was of unknown antigen specificity, failing to lyse targets infected with recombinant VVs expressing the RSV nucleoprotein (N), large glycoprotein, F, 1 A, 1C, or partial matrix protein (amino acid residues 88 to 257) genes. MJC-A2 Tc were cross-reactive for all strains of RSV tested. In contrast, the F-specific MJC-F Tc showed a marked degree of RSV strain specificity, efficiently lysing targets infected with RSV Long or A2 strains, but showing greatly reduced lysis of targets infected with RSV 8/60 or 18537 strains. An anti-RSV human Tc line, IH.K2, also recognized the fusion protein. IH.K2 Tc efficiently lysed autologous Epstein-Barr virus-transformed B cells (BCL) persistently infected with RSV A2 and BCL infected with a VV-RSV F gene recombinant. IH. K2 function was not exclusively RSV F-specific, however, as these cells also lysed autologous BCL infected with a VV-RSV N gene recombinant. These data show that the RSV fusion protein is a target antigen for anti-RSV Tc following infection of mice and humans, and that the F-specific Tc repertoire in mice can be influenced by the method and route of priming.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-1-79
1989-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/1/JV0700010079.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-1-79&mimeType=html&fmt=ahah

References

  1. Bangham C. R. M., Askonas B. A. 1986; Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. Journal of General Virology 67:623–629
    [Google Scholar]
  2. Bangham C. R. M., McMichael A. J. 1986; Specific human cytotoxic T cells recognize B cell lines persistently infected with respiratory syncytial virus. Proceedings of the National Academy of SciencesU.S.A 83:9183–9187
    [Google Scholar]
  3. Bangham C. R. M., Cannon M. J., Karzon D. T., Askonas B. A. 1985; Cytotoxic T-cell response to respiratory syncytial virus in mice. Journal of Virology 56:55–59
    [Google Scholar]
  4. Bangham C. R. M., Openshaw P. J. M., Ball L. A., King A. M. Q., Wertz G. W., Askonas B. A. 1986; Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G) expressed by vaccinia virus recombinants. Journal of Immunology 137:3973–3977
    [Google Scholar]
  5. Bastin J., Rothbard J. B., Davey J., Jones I., Townsend A. 1987; Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by Class I-restricted cytotoxic T lymphocytes. Journal of Experimental Medicine 165:1508–1523
    [Google Scholar]
  6. Beem M. 1967; Repeated infections with respiratory syncytial virus. Journal of Immunology 98:1115–1122
    [Google Scholar]
  7. Belshe R. B., Van Voris L. P., Mufson M. A. 1982; Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. Journal of Infectious Diseases 145:311–319
    [Google Scholar]
  8. Cannon M. J. 1987; Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. Journal of Virological Methods 16:293–301
    [Google Scholar]
  9. Cannon M. J., Stott E. J., Taylor G., Askonas B. A. 1987; Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138
    [Google Scholar]
  10. Cannon M. J., Openshaw P. J. M., Askonas B. A. 1988; Cytotoxic T-cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. Journal of Experimental Medicine 168:1163–1168
    [Google Scholar]
  11. Fernie B. F., Ford E. C., Gerin J. L. 1981; The development of BALB/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proceedings of the Society for Experimental Biology and Medicine 167:83–86
    [Google Scholar]
  12. Fishaut M., Tubergen D., Mcintosh K. 1980; Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. Journal of Pediatrics 96:179–186
    [Google Scholar]
  13. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn O. 1969; Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
    [Google Scholar]
  14. Johnson P. R. JR, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. 1987; Antigenic relatedness between glycoproteins of respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. Journal of Virology 61:3163–3166
    [Google Scholar]
  15. Isaacs D., Bangham C. R. M., McMichael A. J. 1987; Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet ii:769–771
    [Google Scholar]
  16. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
    [Google Scholar]
  17. King A. M. Q., Stott E. J., Langer S. J., Young K. K. Y., Ball L. A., Wertz G. W. 1987; Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. Journal of Virology 61:2885–2890
    [Google Scholar]
  18. Lamprecht C. L., Krause H. E., Mufson M. A. 1976; Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. Journal of Infectious Diseases 134:211–217
    [Google Scholar]
  19. Mufson M. A., örvell C, Rafnar B., Norrby E. 1985; Two distinct subtypes of human respiratory syncytial virus. Journal of General Virology 66:2111–2124
    [Google Scholar]
  20. Pala P., Askonas B. A. 1986; Low responder MHC alleles for Tc recognition of influenza nucleoprotein. Immunogenetics 23:379–384
    [Google Scholar]
  21. Parrott R. H., Kim H. W., Arrobio J. O., Hodes D. S., Murphy B. R., Brandt C. D., Camargo E., Chanock R. M. 1973; Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. American Journal of Epidemiology 98:289–300
    [Google Scholar]
  22. Pemberton R. M., Cannon M. J., Openshaw P. J. M., Ball L. A., Wertz G. W., Askonas B. A. 1987; Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. Journal of General Virology 68:2177–2182
    [Google Scholar]
  23. Prince G. A., Hemming V. G., Horswood R. L., Chanock R. M. 1985a; Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Research 3:193–206
    [Google Scholar]
  24. Prince G. A., Horswood R. L., Chanock R. M. 1985b; Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. Journal of Virology 55:517–520
    [Google Scholar]
  25. Rabin H., Hopkins R. F., Ruscetti F. W., Neubauer R. H., Brown R. L., Kawakami T. G. 1981; Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. Journal of Immunology 127:1852–1856
    [Google Scholar]
  26. Taylor G., Stott E. J., Bew M., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett T. 1984; Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137–142
    [Google Scholar]
  27. Taylor G., Stott E. J., Hayle A. J. 1985; Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. Journal of General Virology 66:2533–2538
    [Google Scholar]
  28. Taylor P. M., Davey J., Howland K., Rothbard J. B., Askonas B. A. 1987; Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics 26:267–272
    [Google Scholar]
  29. Townsend A. R. M. 1987; Recognition of influenza virus proteins by cytotoxic T lymphocytes. Immunologic Research 6:80–100
    [Google Scholar]
  30. Townsend A. R. M., Rothbard J., Gotch F. M., Bahadur G., Wraith D. C., McMichael A. J. 1986; The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968
    [Google Scholar]
  31. Walsh E. E., Schlesinger J. J., Brandriss M. W. 1984; Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infection and Immunity 43:756–758
    [Google Scholar]
  32. Wertz G. W., Stott E. J., Young K. K. Y., Anderson K., Ball L. A. 1987; Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccina virus vectors and protection of vaccinated mice. Journal of Virology 61:293–301
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-1-79
Loading
/content/journal/jgv/10.1099/0022-1317-70-1-79
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error